DISCOVERY GENOMICS, INC.

Address

614 MC KINLEY PL NE
MINNEAPOLIS, MN, -

Information

DUNS: 142797880
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Sleeping Beauty Engineered B Cells for Mucopolysaccharidosis

    Amount: $224,484.00

    DESCRIPTION provided by applicant Mucopolysaccharidosis type I MPS I is an autosomal recessive storage disease caused by the absence of L iduronidase IDUA resulting in systemic accumulation ...

    SBIRPhase I2015Department of Health and Human Services
  2. Diabetes Prevention: Interactive DPP Curriculum for Virtual Small Group Delivery

    Amount: $200,244.00

    DESCRIPTION (provided by applicant): Pancreatic cancer represents the 10th most common cancer diagnosis, yet the 4th most common estimated cause of death. The only potential curative therapy for pancr ...

    SBIRPhase I2013Department of Health and Human Services
  3. Sleeping Beauty-Mediated Gene Therapy for Hemophilia

    Amount: $1,766,286.00

    DESCRIPTION (provided by applicant): Sleeping Beauty (SB) is a transposon system that has been extensively shown to be capable of mediating integration of new gene sequences into the chromosomes of ta ...

    SBIRPhase II2011Department of Health and Human Services
  4. Sleeping Beauty-mediated Gene Therapy of X-linked SCID

    Amount: $270,673.00

    DESCRIPTION (provided by applicant): Primary immune deficiencies comprise a group of inherited genetic disorders caused by interruption of normal lymphoid development. These diseases are considered p ...

    SBIRPhase I2010Department of Health and Human Services
  5. Delivery of Sleeping Beauty Transposons to Dog Liver for Gene Therapy

    Amount: $290,918.00

    DESCRIPTION (provided by applicant): The overall goal of Discovery Genomics, Inc. is to develop the Sleeping Beauty transposon system for human gene therapy. To achieve this to treat hemophilia, we mu ...

    STTRPhase I2008Department of Health and Human Services
  6. Targeted Transposons for Gene Therapy

    Amount: $174,011.00

    DESCRIPTION (provided by applicant): Discovery Genomics, Inc. is focused on development of the Sleeping Beauty (SB) transposon system as a non-viral means of integrating new gene sequences in cells an ...

    STTRPhase I2007Department of Health and Human Services
  7. Transposon-Mediated Gene Therapy for Fanconi Anemia

    Amount: $837,417.00

    DESCRIPTION (provided by applicant): Fanconi anemia (FA) is a rare, autosomal recessive inherited disease caused by the absence of any of eight different proteins that regulate DNA repair. Affected in ...

    SBIRPhase II2007Department of Health and Human Services
  8. Brain Tumor Stem Cell-targeted Gene Therapy

    Amount: $237,878.00

    DESCRIPTION (provided by applicant): Glioblastoma Multiforme (GBM) is a lethal brain tumor that typically causes death within two years after initial diagnosis. GBM accounts for 25% of all primary bra ...

    STTRPhase I2006Department of Health and Human Services
  9. Sleeping Beauty-Mediated Gene Therapy for Hemophilia

    Amount: $1,245,180.00

    DESCRIPTION (provided by applicant): Hemophilia A is a bleeding disorder caused by the absence of clotting factor VIII (FVIII). This disease is inherited in an X-linked recessive manner. There are 15, ...

    SBIRPhase II2005Department of Health and Human Services
  10. Transposon-mediated Gene Therapy for Fanconi Anemia

    Amount: $235,588.00

    DESCRIPTION (provided by applicant): Fanconi anemia (FA) is an inherited recessive disorder caused by deficiency of one of several (up to 9) proteins involved in the regulation of DNA repair. Patients ...

    SBIRPhase I2004Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government